Accessibility Menu
Nautilus Biotechnology Stock Quote

Nautilus Biotechnology (NASDAQ: NAUT)

$1.43
(5.9%)
+0.08
Price as of October 28, 2025, 4:00 p.m. ET

KEY DATA POINTS

Current Price
$1.43
Daily Change
(5.9%) +$0.08
Day's Range
$1.28 - $1.52
Previous Close
$1.43
Open
$1.35
Beta
1.68
Volume
1,497,157
Average Volume
398,278
Market Cap
180.6M
Market Cap / Employee
$1.43M
52wk Range
$0.62 - $2.92
Revenue
-
Gross Margin
-
Dividend Yield
N/A
EPS
-$0.52
CAPs Rating
-
Industry
Life Sciences Tools and Services

The Motley Fool Investing Philosophy: We generally recommend investors buy shares of at least 25 stocks and hold them for at least 5 years. Learn More

Nautilus Biotechnology Return vs. S&P

1 Year5 Year5 Year AnnualizedSince IPO
NAUT-49.11%N/AN/A-86%
S&P+18.33%+108.18%+15.79%+106%

Nautilus Biotechnology Company Info

Nautilus Biotechnology, Inc. is a life sciences company, which engages in the development of a proteomics platform for analyzing and quantifying the human proteome. Its products include Proteome Analysis System, Reagent Kits, and Software and Analysis. The company was founded by Sujal Patel and Parag Mallick in 2016 and is headquartered in Seattle, WA.

Financial Health

General

Q3 2025YOY Change
Revenue$0.00M0.0%
Gross Profit$0.00M100.0%
Market Cap$106.72M-70.1%
Market Cap / Employee$0.69M0.0%
Employees155-7.2%
Net Income-$13.57M17.5%
EBITDA-$13.85M20.8%

Currently no data to display

Revenue Growth Rate

Currently no data to display.

Earnings Per Share Growth Rate

Currently no data to display.

Assets

Q3 2025YOY Change
Net Cash$23.88M441.5%
Inventory00.0%

Liabilities

Q3 2025YOY Change
Long Term Debt$22.79M-17.4%
Short Term Debt$4.21M6.3%

Ratios

Q3 2025YOY Change
Return On Assets-27.27%-3.0%
Return On Invested Capital-20.06%-2.5%

Cash Flow

Q3 2025YOY Change
Free Cash Flow-$11.45M17.1%
Operating Free Cash Flow-$11.03M15.9%

Valuation

MetricQ4 2024Q1 2025Q2 2025Q3 2025YoY Change
Price to Book0.940.520.470.59-61.21%
Price to Tangible Book Value0.940.520.470.59-61.21%
Enterprise Value to EBITDA-18.24-6.500.062.04-122.48%
Return on Equity-29.9%-30.9%-31.6%-32.0%14.11%
Total Debt$30.48M$29.34M$28.18M$27.00M-14.46%

Premium Investing Services

Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.